Eliminate unnecessary animal studies, establish clear conditions for comparative clinical trials, say healthcare advocates

The 2025 Draft Guidelines on Similar Biologics offer an opportunity to advance India’s healthcare system, members of the Working Group on Access to Medicines and Treatment network said

India